Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to communicate complex science clearly and creatively. In an era of omnichannel communication where patient-centricity is the cornerstone of trust and engagement, pharma companies must go beyond traditional formats to deliver content that resonates with healthcare professionals (HCPs), patients, caregivers, and…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to...
ISMPP

21st Annual Meeting of ISMPP: A Summarized Report

The 21st Annual Meeting of ISMPP was held from May 12-14, 2025, in Washington, D.C...
MAPS EMEA 2025

Amplifying the Patient Voice: Reflections from MAPS EMEA 2025

At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the...
equity diversity and inclusion

How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications

A roadmap on how to drive advocacy for EDI in medical communications and publications and...
Building public trust in pharma

3 Factors That Will Help Pharma Build Public Trust

Pharma must engage with patients at all levels to build public trust...
Vaccine

Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy

Read an insightful discussion from the latest ISMPP conference on how science communication and medical...

Learn more ABOUT our company.